Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Juventas Therapeutics logo — Pioneering regenerative therapies for life-threatening disea...

Juventas Therapeutics

Pioneering regenerative therapies for life-threatening diseases with a robust clinical pipeline and a strong foundation in collaboration and innovation.

Founded 2007 Series B Total: $48.72M Biotechnology, Health Care +3

General Information

Company Name Juventas Therapeutics
Founded Year 2007
Industries Biotechnology, Health Care, Health and Wellness +2
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Juventas Therapeutics. To contact Juventas Therapeutics, visit juventasinc.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Juventas Therapeutics compare?

A PDF of Juventas Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Juventas Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Juventas Therapeutics

Juventas Therapeutics is a clinical-stage biotechnology company, founded in 2007, that is dedicated to developing regenerative therapies for life-threatening diseases. With an exclusive license from the Cleveland Clinic, the company has progressed from concept to mid-stage clinical trials. Its investors, including Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co., have provided significant support. Additionally, Juventas Therapeutics has received non-dilutive grants from the Ohio Third Frontier-funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center, and Center for Stem Cell & Regenerative Medicine.

The most recent investment in the company was a $13.50M Series B investment on 12 May 2015, with POSCO Venture Capital and Green Cross as the major investors.

Juventas Therapeutics' commitment to pioneering regenerative therapies for life-threatening diseases has attracted notable support, positioning it as a promising player in the biotechnology and healthcare industries.

Business keywords: clinical-stage biotechnology, regenerative therapies, life-threatening diseases, innovation, Cleveland Clinic, clinical trials, investors, venture capital, regenerative medicine, biomedical research, startup, non-dilutive grants, Ohio Third Frontier, stem cell research

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Series B $13.50M 2
POSCO Venture Capital
POSCO Venture Capital, Green Cross
12 May 2015
Venture Round $5.00M -
20 Nov 2013
Series B $22.20M 8
Early Stage Partners North Coast Ventures New Science Ventures
Early Stage Partners, North Coast Ventures +6
16 Jul 2012
Series A $7.72M -
23 Oct 2008
Pre Seed Round $300.00K -
30 Sep 2008

Juventas Therapeutics Alternatives & Competitors

View All Alternatives
Juventas Therapeutics vs
Athersys
Athersys United States

Committed to developing therapies to extend and enhance the quality of life.

Post-IPO Equity
37 employees
Biopharma, Biotechnology
Compare Juventas Therapeutics vs Athersys
Juventas Therapeutics vs
Aurion Biotech
Aurion Biotech United States

We're on a mission to cure blindness with our transformational platform of advanced therapies

Acquired
94 employees
Biopharma, Biotechnology
Juventas Therapeutics vs
InGeneron
InGeneron United States

Unlocking Regenerative Cell Therapy

Venture round
18 employees
Biotechnology, Health Care
Also compare with: Juventas Therapeutics vs Help Therapeutics Help Therapeutics View all alternatives

FAQ About Juventas Therapeutics

Pioneering regenerative therapies for life-threatening diseases with a robust clinical pipeline and a strong foundation in collaboration and innovation.
Juventas Therapeutics was founded in 2007.
Juventas Therapeutics operates in Biotechnology, Health Care, Health and Wellness, Life Sciences and Medical Devices. Its work centres on clinical-stage biotechnology, regenerative therapies, life-threatening diseases and innovation.
Juventas Therapeutics has completed 5 funding rounds, raising a total of $48.72M. The latest funding stage is Series B.
Top alternatives and competitors to Juventas Therapeutics include Athersys, Aurion Biotech, InGeneron, DiscGenics, Help Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Juventas Therapeutics and Athersys are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Juventas Therapeutics, https://bouncewatch.com/company/juventas-therapeutics, updated 27 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout